Immediate Impact

47 standout
Sub-graph 1 of 19

Citing Papers

Cross-priming in cancer immunology and immunotherapy
2025 Standout
Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy
2025 Standout
2 intermediate papers

Works of Jaroslav Klát being referenced

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial
2022
Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: A virtual brachytherapy study
2014

Author Peers

Author Last Decade Papers Cites
Jaroslav Klát 353 137 180 224 43 473
Ilaria Sabatucci 267 125 214 154 35 522
Tullio Golia D’Augè 228 94 127 152 31 442
Kaoru Okugawa 239 104 160 125 46 425
K. Ohmi 297 98 244 166 24 521
Nicoletta D’Alessandris 312 104 227 90 50 456
Valérie Dubé 277 84 231 163 29 558
Karen L. Talia 316 65 229 207 37 523
Maria Elena Guerrieri 176 166 157 137 27 514
Ian Harley 232 99 206 155 24 489
Carlos Chaves Faloppa 340 89 193 157 44 536

All Works

Loading papers...

Rankless by CCL
2026